Isabell Cardaun

Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease

Leticia Toledo‐Sherman, Michael E. Prime, Ladislav Mrzljak et al. · Journal of Medicinal Chemistry · 2015 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Meso scale discovery-based assays for the detection of aggregated huntingtin

Wolfgang Reindl, Barbara Baldo, Jana Felicitas Schulz et al. · PLoS ONE · 2019 · 52 citations · Full text

Life Sciences, Genetics, Neurology +11

Crystal structure of human peptidylarginine deiminase type VI (PAD6) provides insights into its inactivity

F.M. Ranaivoson, Rieke Bande, Isabell Cardaun et al. · IUCrJ · 2024 · 14 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +10